Implementation of oral versus intravenous antibiotics in clinical practice at a specialized orthopedic infection unit: a descriptive retrospective cohort study.

Background and purpose — The Oral Versus Intravenous Antibiotics (OVIVA) trial demonstrated that oral antibiotic therapy was noninferior to intravenous antibiotic therapy when used during the initial 6 weeks in the treatment of bone and joint infections (BJIs). We aimed to evaluate clinical outcomes...

Descripción completa

Detalles Bibliográficos
Publicado en:Acta Orthopaedica Vol. 96; pp. 677 - 684
Autores principales: BAWER, Robin, PETERLIN, Anton A. N., BAK, Jakob, GOTTLIEB, Hans
Formato: research tables/charts Journal Article
Publicado: Medical Journals Sweden AB 2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=191461422&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 191461422
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17453674
        1BVL
      jtl: Acta Orthopaedica
      issn: 17453674
      maglogo: N
    pubinfo:
      dt: 2025
      vid: 96
      pid: 59195
      pub: Medical Journals Sweden AB
    artinfo:
      ui:
        191461422
        191461422
        191461422
        10.2340/17453674.2025.44571
        191461422
      ppf: 677
      ppct: 7
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Implementation of oral versus intravenous antibiotics in clinical practice at a specialized orthopedic infection unit: a descriptive retrospective cohort study.
      aug:
        au:
          BAWER, Robin
          PETERLIN, Anton A. N.
          BAK, Jakob
          GOTTLIEB, Hans
        affil: Department of Orthopedic Surgery at Copenhagen University Hospital, Herlev Hospital.
      sug:
        subj:
          Antibiotics Administration and Dosage
          Antibiotics Adverse Effects
          Administration, Oral
          Administration, Intravenous
          Bone Diseases, Infectious Drug Therapy
          Treatment Outcomes Evaluation
          Implementation Science
          Protocols
          Human
          Denmark
          Male
          Female
          Academic Medical Centers
          Descriptive Research
          Retrospective Design
          Prospective Studies
          Electronic Health Records
          Hematologic Tests
          Descriptive Statistics
          Data Analysis Software
          Comparative Studies
          Penicillins Therapeutic Use
          Adverse Drug Event
          Gastrointestinal Diseases Complications
          Treatment Failure
          Reoperation
          Osteomyelitis Complications
          Readmission
          Incidence
          Middle Age
          Aged
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Background and purpose — The Oral Versus Intravenous Antibiotics (OVIVA) trial demonstrated that oral antibiotic therapy was noninferior to intravenous antibiotic therapy when used during the initial 6 weeks in the treatment of bone and joint infections (BJIs). We aimed to evaluate clinical outcomes, antibiotic treatment details, and complication rates following the implementation of the OVIVA protocol. Methods — All patients treated for BJIs between September 2019 and September 2020 at the specialized orthopedic infection unit of Herlev Hospital were eligible for inclusion. This study included data on patient demographics, antibiotic regimens, type of infection, microbiology, length of stay, adverse drug reactions, and definite treatment failure at 1 year. Results — A cohort of 129 patients was included. After a median of 7 days of intravenous therapy, 127 patients underwent an early switch to oral antibiotics. The most frequently used class of oral antibiotics was penicillins (68%). Adverse drug reactions, mostly gastrointestinal, occurred in 36% of all patients. Definite treatment failure at 1 year was 13% with oral antibiotics. Conclusion — We found a comparably low failure rate of 13% among patients who were able to transition to oral antibiotics when applying the treatment protocol from the OVIVA study.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N